The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit? uri icon

Overview

authors

  • Chapman, Paul
  • Cranmer, Lee
  • Dixon, W G
  • Hyrich, K L
  • Patterson, John R
  • Symmons, D P M
  • Toporcer, Mary
  • Mastrangelo, Michael J

publication date

  • February 1, 2010

Research

keywords

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Neoplasms, Second Primary
  • Receptors, Tumor Necrosis Factor

Identity

Scopus Document Identifier

  • 76749164739

Digital Object Identifier (DOI)

  • 10.1053/j.seminoncol.2010.01.001

PubMed ID

  • 20172358

Additional Document Info

volume

  • 37

issue

  • 1